
The coordination of cell proliferation and fate specification is
central to the development and maintenance of tissues. In development, systems
must be tightly-regulated to ensure that precise numbers of lineage-specified
cells are generated in the correct sequence whilst, in adult, a delicate
balance between proliferation and differentiation is essential for
homeostasis. Through a programme of interdisciplinary and collaborative
research, our group is interested in establishing unifying principles of stem
cell regulation in the development and maintenance of tissues, and to use
them to resolve pathways leading to dysregulation in diseased states.
Theories of tissue maintenance place stem cells at the apex of proliferative hierarchies, possessing the lifetime property of self-renewal. In homeostasis the number of stem cells remains fixed imposing an absolute requirement for fate asymmetry in the daughters of dividing cells, such that only half are retained. Fate asymmetry can be achieved either by being the invariant result of every division or by being orchestrated from the whole population, where cell fate following stem cell division is specified only up to some probability. These alternative models suggest different mechanisms of fate regulation, yet their identification in most tissues has remained elusive.
By drawing upon concepts from physics and mathematics, we have shown that strategies of stem cell self-renewal can be classified according to whether fate is specified by internal or extrinsic factors, and whether it leads to invariant asymmetric self-renewal or population asymmetry. As well as achieving a functional classification of stem cell types, this identification provides a general framework that we are using to interpret lineage tracing data. To develop this programme, we are involved in multiple collaborations, addressing different tissue types from epidermis and gut, to retina and germline. Current collaborators include Erika Bach, Cedric Blanpain, Lazaro Centanin, Hans Clevers, Sam Janes, Phil Jones, Allon Klein, Alfonso Martinez-Arias, Emma Rawlins, Wolf Reik, Hongjun Song, Doug Winton, Jochen Wittbrodt, and Shosei Yoshida.
In a related programme, we are also using lineage tracing methodologies to
elucidate patterns of progenitor cell fate in the late stage development of
tissues. Current collaborators include
Cedric Blanpain
(prostate and heart),
Rick Livesey and
Magdalena Goetz (cortex),
Bill Harris and
Michel Cayouette
(retina),
Kim Jensen (intestine),
Anna Philpott and
Jenny Nichols (pancreas
and diabetes), and
Fiona Watt (dermis).
Finally, we are also making use of lineage tracing methods to investigate how
stem and progenitor cells become subverted in tumour-initiation. Current
collaborators include
Hans Clevers
(intestinal adenomas),
Cedric Blanpain and
Phil Jones (skin tumours),
Tony Green (leukaemia), and
Colin Watts (glioblastoma).